Gene Therapy

BRISBANE, Calif., August 6, 2026 Pacira BioSciences announced the publication of positive two-year Phase 1 clinical trial results for...

Taiwan, August 6, 2026 Senhwa Biosciences, Inc. has received Taiwan Food and Drug Administration (TFDA) clearance for a multicenter...

Boston, Massachusetts, August 5, 2026 Galibra Neuroscience has received both Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation...

Brooklyn, New York, August 5, 2026 Phoenix Nest Inc. has been awarded a $2,984,658 Small Business Innovation Research (SBIR)...

NEW YORK, August 5, 2026 Lexeo Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative...

BOSTON, Aug. 3, 2026 Seaport Therapeutics, Inc. reported its second-quarter 2026 financial results while highlighting continued progress across its...

BENGALURU, India, and BRIDGEWATER, N.J., Aug. 3, 2026 Biocon Limited has announced the U.S. commercial launch of Yesafili™ (aflibercept-jbvf),...

RAMAT GAN, Israel, Aug. 3, 2026 Can-Fite BioPharma Ltd. has launched its first clinical development program evaluating Piclidenoson for...

RESEARCH TRIANGLE PARK, N.C., Aug. 3, 2026 Opus Genetics, Inc. has completed patient enrollment in its registrational Phase 3...

MALVERN, Pa., July 29, 2026 Ocugen, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative...